Epidemiology and issues of NIV-treated AECOPD patients with hypercapnic respiratory failure in Shanghai: A multicentre retrospective survey.

The Clinical Respiratory Journal
Sheng-Mei WangShanghai Primary Respiratory Care Union, Shanghai Respiratory Society

Abstract

To investigate the epidemiology, clinical features, treatment and outcome of Noninvasive ventilation (NIV)-treated acute exacerbation of chronic obstructive pulmonary disease (AECOPD) patients in secondary hospitals of Shanghai. Relying on Shanghai alliances for respiratory diseases, a retrospective observational study was performed in 34 secondary hospitals of Shanghai. The AECOPD patients treated with NIV and admitted to the respiratory department or respiratory intensive care unit were recruited between December 1, 2016, and November 30, 2017. There were 555 patients finally recruited in this study. The age was 75.8 ± 9.6 years old and 380 patients (68.5%) were male. 70.5% of all patients had respiratory acidosis (pH <7.35). 55.3% of all patients received nebulised bronchodilator and 77.7% were treated with systemic or inhaled corticosteroids during hospitalisation. 525 patients (94.6%) recovered successfully and the mortality was 3.2%. The hospitalisation was 15.3 ± 6.7 days and hospital expenses were 22 911 ± 13 595 RMB. Inadequate and nonstandard drug treatments were the most important problems during management. The NIV can be successfully used for AECOP patients in local hospitals of Shanghai, but accompanied by high co...Continue Reading

References

Sep 28, 1995·The New England Journal of Medicine·L BrochardF Lemaire
Jun 1, 1995·American Journal of Respiratory and Critical Care Medicine·N KramerN S Hill
Mar 1, 1997·American Journal of Respiratory and Critical Care Medicine·T C O'ShaughnessyP K Jeffery
Nov 11, 1999·American Journal of Respiratory and Critical Care Medicine·G BalzanoG Melillo
Jun 25, 2004·The New England Journal of Medicine·James C HoggPeter D Paré
Feb 16, 2007·The European Respiratory Journal·R SivaI D Pavord
Sep 1, 2009·Lancet·Sundeep S Salvi, Peter J Barnes
Dec 2, 2009·Respirology : Official Journal of the Asian Pacific Society of Respirology·Mat HollandMarta Babores
Aug 31, 2010·American Journal of Respiratory and Critical Care Medicine·Mark D EisnerUNKNOWN Committee on Nonsmoking COPD, Environmental and Occupational Health Assembly
Jun 18, 2011·American Journal of Respiratory and Critical Care Medicine·Mona BafadhelChristopher E Brightling
Feb 13, 2013·Journal of Hospital Medicine : an Official Publication of the Society of Hospital Medicine·Chu-Lin TsaiCarlos A Camargo
Oct 18, 2014·The European Respiratory Journal·Dave SinghUNKNOWN ECLIPSE investigators
Sep 24, 2015·International Journal of Chronic Obstructive Pulmonary Disease·Cüneyt SaltürkSelahattin Oztas
Oct 24, 2015·The European Respiratory Journal·Sylvia HartlC Michael Roberts
Dec 8, 2015·American Journal of Respiratory and Critical Care Medicine·Signe Vedel-KroghBørge G Nordestgaard
Jun 23, 2016·International Journal of Chronic Obstructive Pulmonary Disease·Murat YalcinsoyZuhal Karakurt
Aug 19, 2016·International Journal of Chronic Obstructive Pulmonary Disease·Begum Ergan, Recai Ergün
Sep 7, 2016·The Lancet. Respiratory Medicine· The Lancet Respiratory Medicine
Oct 14, 2017·The European Respiratory Journal·Viktoriya L KimUNKNOWN AERIS Study Group
Jul 20, 2019·BMC Pulmonary Medicine·Alexandru T SteriadeDragos Bumbacea
Jan 11, 2020·International Journal of Chronic Obstructive Pulmonary Disease·Hong-Xia WuDe-Yun Cheng

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.